|
|
Prepublished online as a Blood First Edition Paper on May 17, 2002; DOI 10.1182/blood-2002-02-0387.
Previous Article | Table of Contents | Next Article 
Blood, 15 September 2002, Vol. 100, No. 6, pp. 2040-2045
HEMATOPOIESIS
X-linked thrombocytopenia with thalassemia from a mutation in the
amino finger of GATA-1 affecting DNA binding rather than FOG-1
interaction
Channing Yu,
Kathy K. Niakan,
Mark Matsushita,
George Stamatoyannopoulos,
Stuart H. Orkin, and
Wendy H. Raskind
From the Division of Hematology/Oncology, Department of
Medicine, Children's Hospital and Harvard Medical School, Boston;
Howard Hughes Medical Institute, Boston; Department of Pediatric
Oncology, Dana-Farber Cancer Institute, Boston, MA; and Division of
Medical Genetics, Department of Medicine, University of Washington,
Seattle.
Transcription factor GATA-1 is essential for the development of
erythroid cells and megakaryocytes. Each of its 2 zinc fingers is
critical for normal function. The C-terminal finger is necessary for
DNA binding. The N finger mediates interaction with FOG-1, a cofactor
for GATA-1, and also modulates DNA-binding affinity, notably at complex
or palindromic GATA sites. Residues of the N finger-mediating
interaction with FOG-1 lie on the surface of the N finger facing away
from DNA. Strong sequence conservation of residues facing DNA suggests
that this other surface may also have an important role. We report here
that a syndrome of X-linked thrombocytopenia with thalassemia in humans
is caused by a missense mutation (Arg216Gln) in the GATA-1 N finger. To
investigate the functional consequences of this substitution, we used
site-directed mutagenesis to alter the corresponding residue in GATA-1.
Compared with wild-type GATA-1, Arg216Gln GATA-1 shows comparable
affinity to single GATA sites but decreased affinity to palindromic
sites. Arg216Gln GATA-1 interacts with FOG-1 similarly with wild-type GATA-1. Arg216Gln GATA-1 supports erythroid maturation of GATA-1 erythroid cells, albeit at reduced efficiency compared with wild-type GATA-1. Together, these findings suggest that residues of the N finger
of GATA-1-facing DNA contribute to GATA-1 function apart from
interaction with the cofactor FOG-1. This is also the first example of
-thalassemia in humans caused by a mutation in an erythroid
transcription factor.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. E. Elagib, I. S. Mihaylov, L. L. Delehanty, G. C. Bullock, K. D. Ouma, J. F. Caronia, S. L. Gonias, and A. N. Goldfarb
Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation
Blood,
December 15, 2008;
112(13):
4884 - 4894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Balduini, E. De Candia, and A. Savoia
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome"
Blood,
October 1, 2007;
110(7):
2770 - 2771.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Nurden and P. Nurden
Inherited thrombocytopenias
Haematologica,
September 1, 2007;
92(9):
1158 - 1164.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Tubman, J. E. Levine, D. R. Campagna, R. Monahan-Earley, A. M. Dvorak, E. J. Neufeld, and M. D. Fleming
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Blood,
April 15, 2007;
109(8):
3297 - 3299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Phillips, D. P. Steensma, M. A. Pulsipher, G. J. Spangrude, and J. P. Kushner
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
Blood,
March 15, 2007;
109(6):
2618 - 2621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ghinassi, M. Sanchez, F. Martelli, G. Amabile, A. M. Vannucchi, G. Migliaccio, S. H. Orkin, and A. R. Migliaccio
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor
Blood,
February 15, 2007;
109(4):
1460 - 1471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Majewski, D. Metcalf, L. A. Mielke, D. L. Krebs, S. Ellis, M. R. Carpinelli, S. Mifsud, L. Di Rago, J. Corbin, N. A. Nicola, et al.
A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia
PNAS,
September 19, 2006;
103(38):
14146 - 14151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Stachura, S. T. Chou, and M. J. Weiss
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1
Blood,
January 1, 2006;
107(1):
87 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iolascon, M. d'Apolito, V. Servedio, F. Cimmino, A. Piga, and C. Camaschella
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)
Blood,
January 1, 2006;
107(1):
349 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Phillips, D. P. Steensma, G. J. Spangrude, and J. P. Kushner
Congenital Erythropoietic Porphyria, {beta}-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
515 - 515.
[Abstract]
|
 |
|

|
 |

|
 |
 
C. Kuhl, A. Atzberger, F. Iborra, B. Nieswandt, C. Porcher, and P. Vyas
GATA1-Mediated Megakaryocyte Differentiation and Growth Control Can Be Uncoupled and Mapped to Different Domains in GATA1
Mol. Cell. Biol.,
October 1, 2005;
25(19):
8592 - 8606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Munugalavadla, L. C. Dore, B. L. Tan, L. Hong, M. Vishnu, M. J. Weiss, and R. Kapur
Repression of c-Kit and Its Downstream Substrates by GATA-1 Inhibits Cell Proliferation during Erythroid Maturation
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6747 - 6759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson
Selective impairment of platelet activation to collagen in the absence of GATA1
Blood,
June 1, 2005;
105(11):
4369 - 4376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zahirieh, M. A. Nesbit, A. Ali, K. Wang, N. He, M. Stangou, G. Bamichas, K. Sombolos, R. V. Thakker, and Y. Pei
Functional Analysis of a Novel GATA3 Mutation in a Family with the Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome
J. Clin. Endocrinol. Metab.,
April 1, 2005;
90(4):
2445 - 2450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ferreira, K. Ohneda, M. Yamamoto, and S. Philipsen
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Mol. Cell. Biol.,
February 15, 2005;
25(4):
1215 - 1227.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Liew, R. J. Y. Simpson, A. H. Y. Kwan, L. A. Crofts, F. E. Loughlin, J. M. Matthews, M. Crossley, and J. P. Mackay
Zinc fingers as protein recognition motifs: Structural basis for the GATA-1/Friend of GATA interaction
PNAS,
January 18, 2005;
102(3):
583 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Thein
Pathophysiology of {beta} Thalassemia--A Guide to Molecular Therapies
Hematology,
January 1, 2005;
2005(1):
31 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Welch, J. A. Watts, C. R. Vakoc, Y. Yao, H. Wang, R. C. Hardison, G. A. Blobel, L. A. Chodosh, and M. J. Weiss
Global regulation of erythroid gene expression by transcription factor GATA-1
Blood,
November 15, 2004;
104(10):
3136 - 3147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Nesbit, M. R. Bowl, B. Harding, A. Ali, A. Ayala, C. Crowe, A. Dobbie, G. Hampson, I. Holdaway, M. A. Levine, et al.
Characterization of GATA3 Mutations in the Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) Syndrome
J. Biol. Chem.,
May 21, 2004;
279(21):
22624 - 22634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ahmed, A. Sternberg, G. Hall, A. Thomas, O. Smith, A. O'Marcaigh, R. Wynn, R. Stevens, M. Addison, D. King, et al.
Natural history of GATA1 mutations in Down syndrome
Blood,
April 1, 2004;
103(7):
2480 - 2489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shimizu, K. Ohneda, J. D. Engel, C. D. Trainor, and M. Yamamoto
Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia
Blood,
April 1, 2004;
103(7):
2560 - 2567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Drachman
Inherited thrombocytopenia: when a low platelet count does not mean ITP
Blood,
January 15, 2004;
103(2):
390 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gurbuxani, P. Vyas, and J. D. Crispino
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome
Blood,
January 15, 2004;
103(2):
399 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Higgs
Ham-Wasserman Lecture: Gene Regulation in Hematopoiesis: New Lessons from Thalassemia
Hematology,
January 1, 2004;
2004(1):
1 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ghirlando and C. D. Trainor
Determinants of GATA-1 Binding to DNA: THE ROLE OF NON-FINGER RESIDUES
J. Biol. Chem.,
November 14, 2003;
278(46):
45620 - 45628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fossett, K. Hyman, K. Gajewski, S. H. Orkin, and R. A. Schulz
Combinatorial interactions of Serpent, Lozenge, and U-shaped regulate crystal cell lineage commitment during Drosophila hematopoiesis
PNAS,
September 30, 2003;
100(20):
11451 - 11456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rainis, D. Bercovich, S. Strehl, A. Teigler-Schlegel, B. Stark, J. Trka, N. Amariglio, A. Biondi, I. Muler, G. Rechavi, et al.
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21
Blood,
August 1, 2003;
102(3):
981 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mundschau, S. Gurbuxani, A. S. Gamis, M. E. Greene, R. J. Arceci, and J. D. Crispino
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
Blood,
June 1, 2003;
101(11):
4298 - 4300.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|